Saturday, 11 July 2020

Schrödinger inks strategic collaboration with Thermo Fisher

26 June 2020 | News

Schrödinger will identify drug discovery targets and Thermo Fisher will obtain cryo-EM structures of these targets

Image credit- shutterstock.com

Image credit- shutterstock.com

US based Schrödinger has announced a strategic collaboration with Thermo Fisher Scientific to extend the use of cryo-EM in connection with in silico compound screening to accelerate drug discovery.

The collaboration brings together Schrödinger’s physics-based software platform with Thermo Fisher’s world-leading cryo-EM technology to expand the applicability of structure-based drug discovery to a wider array of targets which may not be amenable to structure prediction via x-ray crystallography.

Schrödinger will identify drug discovery targets and Thermo Fisher will obtain cryo-EM structures of these targets with bound ligands. Schrödinger will then leverage its advanced computational platform, together with the cryo-EM structures, to identify development candidates.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account